LINC00398: A Potential Drug Target and Biomarker (G100874158)

Target Name: LINC00398

NCBI ID: G100874158

LINC00398

Other Name(s): long intergenic non-protein coding RNA 398 | Long intergenic non-protein coding RNA 398

LINC00398: A Potential Drug Target and Biomarker

LINC00398 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the LINC family of RNA-binding proteins, which are known for their ability to interact with RNA molecules. LINC00398 has been shown to play a role in a variety of physiological processes, including cell signaling, DNA replication, and metabolism.

One of the key features of LINC00398 is its ability to interact with the protein p21, which is a well-known tumor suppressor protein that is expressed in many types of cancer. p21 is a transcription factor that has been shown to play a role in regulating cell growth and apoptosis, which are important processes that help prevent cancer from spreading.

In addition to its potential role in cancer regulation, LINC00398 has also been shown to be involved in a variety of other biological processes. For example, it has been shown to play a role in cell signaling, as well as in the regulation of DNA replication and metabolism.

Given its involvement in a variety of important biological processes, LINC00398 is an attractive target for drug development. Researchers have been exploring the use of small molecules and other compounds to modulate the activity of LINC00398, with the goal of developing new treatments for a variety of diseases.

One approach that researchers have taken to study LINC00398 is to use a technique called RNA profiling. This involves the use of RNA-seq, which is a powerful tool for analyzing the expression of RNA molecules in a variety of organisms. By analyzing the expression levels of LINC00398 in different samples, researchers have been able to gain insights into its role in various biological processes.

In addition to its potential as a drug target, LINC00398 has also been shown to be a potential biomarker for a variety of diseases. For example, studies have shown that LINC00398 is downregulated in a variety of cancer types, which suggests that it may be a useful biomarker for these diseases. Additionally, LINC00398 has been shown to be downregulated in a variety of diseases, including neurodegenerative disorders and cardiovascular disease.

Overall, LINC00398 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role in these processes and to develop new treatments based on its properties.

Protein Name: Long Intergenic Non-protein Coding RNA 398

The "LINC00398 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00398 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets